Makindo Medical Notes"One small step for man, one large step for Makindo" |
|
|---|---|
| Download all this content in the Apps now Android App and Apple iPhone/Pad App | |
| MEDICAL DISCLAIMER: The contents are under continuing development and improvements and despite all efforts may contain errors of omission or fact. This is not to be used for the assessment, diagnosis, or management of patients. It should not be regarded as medical advice by healthcare workers or laypeople. It is for educational purposes only. Please adhere to your local protocols. Use the BNF for drug information. If you are unwell please seek urgent healthcare advice. If you do not accept this then please do not use the website. Makindo Ltd. |
Related Subjects:
|Acute Severe Colitis
|Ulcerative Colitis
|Microscopic colitis
|Irritable bowel syndrome
|Lower Gastrointestinal (Rectal) Bleeding
π₯ Ulcerative colitis (UC) = a relapsing-remitting inflammatory disease of the colon, with continuous mucosal inflammation starting in the rectum.
β οΈ Risks: acute severe colitis (medical emergency) + β risk of colorectal cancer.
Always starts in the rectum (proctitis) and extends proximally in a continuous manner.
π‘ Teaching Tip: In exams, remember the mnemonic:
π About
𧬠Aetiology
πΊοΈ Extent of Disease
π©Ί Clinical Presentation
π Extra-intestinal Features
π§ͺ Pathology
π Assessing Severity (Modified Truelove & Wittsβ Criteria)
Severity Features
π Mild <4 bloody stools/day; no systemic upset; Hb >115; CRP <5
π Moderate 4β6 stools/day; mild systemic disturbance; Hb >105; CRP <30
π Severe >6 bloody stools/day + systemic features (T >37.8, HR >90, Hb <105, CRP >30)
π¨ Fulminant β₯10 stools/day, continuous bleeding, severe toxicity, colonic dilatation on AXR
π Investigations
π Comparison: Crohnβs Disease vs Ulcerative Colitis
Feature
π± Crohnβs Disease
π₯ Ulcerative Colitis
Distribution
Anywhere mouth β anus, most often terminal ileum; skip lesions
Starts in rectum, continuous spread proximally through colon
Depth of Inflammation
Transmural (full thickness)
Mucosa + submucosa only
Histology
Non-caseating granulomas, fissures
Crypt abscesses, mucosal ulceration, no granulomas
Appearance
βCobblestoneβ mucosa, thick bowel wall, strictures, fistulas
Red, raw, friable mucosa, pseudopolyps
Symptoms
RLQ pain, weight loss, diarrhoea (Β± blood), perianal disease
Bloody diarrhoea, urgency, tenesmus, LLQ pain
Smoking
π¬ Risk factor (worsens disease)
π Protective (symptoms often worse in ex-smokers)
Extra-intestinal
More renal stones (oxalate), gallstones, B12 deficiency
PSC (primary sclerosing cholangitis), β colorectal cancer risk
Fistula/Stricture
β
Common (entero-enteric, perianal, entero-vesical)
β Rare
Surgery
Not curative (recurs in new bowel segments)
Curative (colectomy removes disease)
Cancer risk
Increased with colonic involvement
High with long-standing pancolitis or PSC
| Step | Treatment |
|---|---|
| 1 | 5-ASA (Mesalazine, Sulfasalazine) Β± rectal 5-ASA for distal disease |
| 2 | Rectal steroids |
| 3 | Oral steroids (Prednisolone 40β60 mg, tapered) |
| 4 | IV steroids (Hydrocortisone, Methylprednisolone) |
| 5 | Immunomodulators (Azathioprine, 6-Mercaptopurine) |
| 6 | Biologics (Infliximab, Vedolizumab) or IV Ciclosporin |
| 7 | Surgery (panproctocolectomy + ileoanal pouch) |
π‘ Teaching Pearls:
β UC = continuous, mucosal-only inflammation starting at rectum (vs Crohnβs = skip lesions, transmural).
β Acute severe colitis = emergency: IV steroids first, colectomy if no response.
β Long-term risk: colorectal cancer β surveillance colonoscopy.
β Extra-intestinal features (skin, eyes, joints, liver) often parallel disease activity.
Ulcerative colitis is a chronic inflammatory bowel disease with continuous mucosal inflammation starting at the rectum. β’ Case 1 shows typical mildβmoderate disease, often well controlled with 5-ASA. β’ Case 2 illustrates severe acute colitis β a medical emergency needing IV steroids and close monitoring. β’ Case 3 highlights toxic megacolon π©, a life-threatening complication requiring urgent surgery. Long-term complications include colorectal cancer, so patients need regular colonoscopic surveillance after 8β10 years of disease duration.